2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]
- RxCUI
- 2699122
- RxNorm name
- 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]
- Display name
- 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]
- Full name
- 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761151 | Bimzelx | bimekizumab-bkzx | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bimzelx | BIMEKIZUMAB | UCB, Inc. | 26b88358-871f-4c80-9d80-b2fb16477f81 | 2025-06-16 | Warnings, Adverse reactions | 2699122 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 26b88358-871f-4c80-9d80-b2fb16477f81 | 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] | SBD | 14 | These highlights do not include all the information needed to use BIMZELX safely and effectively. See full prescribing information for BIMZELX. BIMZELX® (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023 | 20250616 |
| 26b88358-871f-4c80-9d80-b2fb16477f81 | Bimzelx 320 MG per 2 ML Auto-Injector | SY | 14 | These highlights do not include all the information needed to use BIMZELX safely and effectively. See full prescribing information for BIMZELX. BIMZELX® (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023 | 20250616 |
| 26b88358-871f-4c80-9d80-b2fb16477f81 | Bimzelx 320 MG in 2 ML Auto-Injector | PSN | 14 | These highlights do not include all the information needed to use BIMZELX safely and effectively. See full prescribing information for BIMZELX. BIMZELX® (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023 | 20250616 |